MedPath

University of Massachusetts Amherst

University of Massachusetts Amherst logo
🇺🇸United States
Ownership
Private
Established
1863-01-01
Employees
1K
Market Cap
-
Website
http://www.umass.edu

Study Reveals Effective Strategies for Young Adults Quitting Vaping

• Nearly half of young adults successfully quit vaping after three months using a combination of phone-based coaching, health apps, and nicotine replacement therapy, according to new research published in the American Journal of Preventive Medicine. • Text-based support programs offering motivational messages and quitting tips have emerged as one of the most effective interventions for helping younger populations break their nicotine addiction, a systematic evidence review found. • Researchers were surprised to discover that phone-based quitline coaching was highly effective and well-received among 18-24 year olds, challenging assumptions that this demographic would prefer text-based support over telephone conversations.

Non-Toxic Bacteria Cancer Treatment Advances Toward Clinical Trials

A groundbreaking non-toxic bacterial therapy, BacID, developed by a University of Massachusetts Amherst-Ernest Pharmaceuticals team, is set to enter clinical trials by 2027. This innovative treatment aims to deliver cancer-fighting drugs directly into tumors, offering a safer and more effective alternative to traditional therapies like chemotherapy. The technology leverages genetically engineered Salmonella strains to target tumors precisely, minimizing damage to healthy tissues and maximizing therapeutic impact.
© Copyright 2025. All Rights Reserved by MedPath